Arsenic trioxide induces apoptosis in uveal melanoma cells through the mitochondrial pathway

Miao-Ju Chen1, Pei-Yu Yang, Yi-Zhen Ye

  • 1Department of Medical Research, Show Chwan Memorial Hospital, Changhua, Taiwan.

Insights

Arsenic trioxide (ATO) effectively inhibits human uveal melanoma cell growth by inducing apoptosis. This occurs primarily through the mitochondria-dependent pathway, offering potential for improved clinical treatments.

Area of Science:

  • Oncology
  • Cell Biology
  • Pharmacology

Background:

  • Uveal melanoma is the most common primary intraocular malignancy in adults.
  • It exhibits high resistance to conventional chemotherapeutic agents.
  • Arsenic trioxide (ATO) shows promise in inhibiting ocular melanoma cell growth, but its mechanisms are not fully understood.

Purpose of the Study:

  • To investigate the mechanisms of arsenic trioxide (ATO) in inhibiting human uveal melanoma cells.
  • To evaluate the dose- and time-dependent effects of ATO on uveal melanoma cell proliferation.
  • To elucidate the specific apoptotic pathway induced by ATO in uveal melanoma.

Main Methods:

  • MTT assay to assess cell proliferation and viability.
  • Measurement of apoptosis ratio via DNA fragmentation.
  • Analysis of caspase activities (caspase-3, -9, and -8).
  • Western blot analysis for key apoptosis-related proteins (Bax, Bcl-2, cytochrome c).

Main Results:

  • ATO demonstrated a stronger inhibiting effect on uveal melanoma (SP6.5) cell proliferation compared to human fibroblasts.
  • ATO treatment significantly increased the apoptosis ratio in SP6.5 cells (4.1- to 7.7-fold).
  • ATO elevated caspase-3 and caspase-9 activities, enhanced Bax and cytochrome c expression, and suppressed Bcl-2 expression.

Conclusions:

  • Arsenic trioxide (ATO) induces apoptosis in human uveal melanoma cells primarily through the mitochondrial pathway.
  • The study provides the first comprehensive evaluation of the mitochondria-dependent apoptotic pathway of ATO in uveal melanoma.
  • These findings suggest potential for enhancing the clinical efficacy of ATO for uveal melanoma treatment.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...